Scilex Holding (SCLXW) Accumulated Expenses (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Accumulated Expenses of $247.5 million in Q1 2026, up 7468.81% quarter-over-quarter from $3.3 million in Q4 2025, and up 14863.72% on a YoY basis from N/an in Q1 2025.

Scilex Holding (SCLXW) Accumulated Expenses (2021 - 2026) Analysis & Trends

Scilex Holding's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $247.5 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 14863.72% year-over-year to $247.5 million; the TTM figure through Mar 2026 stood at $247.5 million (up 14863.72% YoY), while the FY2025 annual figure was $3.3 million, down 97.99% from the prior year.
  • Accumulated Expenses was $247.5 million for Q1 2026 at Scilex Holding, up from $3.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $247.5 million in Q1 2026 to a low of $500000.0 in Q1 2024.
  • Historically, Accumulated Expenses has averaged $33.4 million across 5 years, with a median of $2.7 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Accumulated Expenses plunged 97.99% in 2025, then surged 14863.72% in 2026.
  • A 5-year view of Accumulated Expenses shows it stood at $1.4 million in 2022, then jumped by 98.01% to $2.7 million in 2023, then jumped by 5961.17% to $162.5 million in 2024, then slumped by 97.99% to $3.3 million in 2025, then jumped by 7468.81% to $247.5 million in 2026.
  • The last three Accumulated Expenses figures came in at $247.5 million (Q1 2026), $3.3 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 247.50 Mn
Dec 31, 2025 3.27 Mn
Sep 30, 2025 2.95 Mn
Jun 30, 2025 1.63 Mn
Mar 31, 2025 1.65 Mn
Dec 31, 2024 162.50 Mn
Jun 30, 2024 4.07 Mn
Mar 31, 2024 500,000.00
Dec 31, 2023 2.68 Mn
Sep 30, 2023 1.92 Mn
Jun 30, 2023 2.75 Mn
Mar 31, 2023 1.71 Mn
Dec 31, 2022 1.35 Mn
Dec 31, 2021 3.73 Mn